B4-RNA

United States
Lander, Wyoming, United States, 11400

Company profile

B4-RNA company profile

B4RNA is a biotechnology company developing a liquid biopsy diagnostic for early cancer detection using a proprietary RNA repair and sequencing method. The company is in the preclinical trial phase and has received $1.25 million in funding, preparing for a pre-Series A round to expand clinical trials and launch operations in the United States.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2024-01-25

Headquarters

Postal code
11400
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$750,000
Last funding
Pre Seed / $750,000 / 2024-03-05
Last equity funding
Pre Seed / $750,000
Founders
1

Categories and groups

Founders and investors

Founders

Juan Pablo Tosar